Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Tissue Sterilization Process Proven Effective

By HospiMedica staff writers
Posted on 17 Aug 2004
More than 540,000 implants sterilized with a patented tissue sterilization process called BioCleanse have been distributed with no incidence of graft-related infection.

Standard methods to prepare tissue for transplant include screening for diseases, bacterial testing, and aseptic processing, all of which help to reduce the risk to patients but are not sufficient to eliminate the risk of allograft-associated infections in recipients. More...
The BioCleanse method, developed and patented by Regeneration Technologies, Inc. (RTI, Alachua, FL, USA), is a proven tissue sterilization process, validated to eliminate viruses, bacteria, fungi, and spores from tissue without affecting the structural biomechanical integrity of the allograft.

RTI processes allograft tissue into shaped implants for use in orthopedic, cardiovascular, and other surgeries, enabling patients to benefit from the gift of donated tissues. "Donor families entrust us with their gift of donation because they know through our innovations, we will serve as responsible stewards of each gift by safely helping as many people as possible,” remarked Brian K. Hutchison, chairman, president, and CEO of RTI. The company was named a 2004 Technology Pioneer by the World Economic Forum.




Related Links:
RTI

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Cardiograph Device
PageWriter TC35
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.